SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  RESOURCE CENTER  
  JOBS  
  SUBSCRIBE  
 RSS
  Monday, March 22, 2010 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

Japanese medical technology
PRIME NEWS
Affymax gets $5mn milestone payment from Takeda
American pharma company Affymax has received a $5 mn development milestone payment from Japan's Takeda Pharmaceutical
Shionogi to market QuatRx Pharmas' Ospemifene
Japanese pharma company Shionogi and QuatRx Pharmaceuticals, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator
TODAY'S NEWS
  Valeant to buy branded generics company in Brazil
  Chugai files for anti-cancer agents Herceptin, Xeloda
  Aurobindo gets Canadian nod for for Topiramate Tablets
  Strides to acquire 100% interest in oncology JVs
  PPD, SRI sign agreement for vax clinical research services
  ABRAXANE meets primary endpoint in phIII trial for advanced NSCLC

BioSpectrum Japan is uniquely positioned as a specialized information platform for Japanese medical technology articles. It brings to you comprehensive coverage and useful Japan medical news in the areas of pharmaceuticals industry in Japan, Japanese medical technology, Japan medical devices and Biotech.
Advertisement
 
Digital Mag
Read on some of the best articles published in 2009

Issue: February, 2010
Current Issue
View / Download
Top Story
India puts bt brinjal on hold
 
 
 
Print Edition
Issue: March 2010
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement











 

NEWS
Quintiles announces new Central Lab in Japan
Quintiles, a fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide has successfully relocated its Global Central Laboratory in Japan from Saitama to Tokyo to allow for expansion
Medicago, NITT to develop vax in Japan
Medicago, a biotechnology company has signed a MoU with Niigata TLO/NBRP/KUTLO-NITT (NITT Partners) to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in Japan and other countries
FEATURES
OutBound: Japan industry on the move
The future is in innovative R&D and export markets
A lot of players will emerge in the stem cell industry"
Stem cell related businesses will organically diversify into cell therapy, drug discovery, tailor-made medicine, and research reagents
PEOPLE
GSK Japan gets new President
GlaxoSmithKline has appointed Mr Philippe Fauchet as the President of GSK Japan. Mr Fauchet joins GSK from Sanofi Aventis where he was Senior Vice President, Business Development
Nu Skin Japan appoints Dr Makoto Kuro-O to its SAB
Nu Skin Japan also announced Dr Makoto Kuro-O, associate professor of pathology at the University of Texas Southwestern Medical Center, as a new member of its Anti-Aging Scientific Advisory Board (SAB)
EVENTS
TriNation Health Tech Forum: American Cities to share med tech advances with Japan
The Forum is focused on bringing together the medical devices and e-health technology communities of Western Canada, Washington State and Oregon with delegates from Japan
Medidata participates in clinical data workshop in Japan
Medidata Solutions announced that its top executives will present at the 11th Annual Workshop for Clinical Data Management in Tokyo, Japan
R & D
RIKEN researchers trace proteins that help plants keep time
Researchers at the RIKEN Plant Science Center in Japan have clarified the function of three proteins that play a central role in the circadian clock in plants. The finding, to appear in the journal The Plant Cell, opens the door to the engineering
Japanese researchers trace HMGB1 protein that triggers islet cell rejection
Researchers at RIKEN and Fukuoka University in Japan have pinpointed the mechanism responsible for early rejection of transplanted pancreatic islet cells in the treatment of type 1 diabetes, also known as juvenile diabetes. A new system based on this
POLICIES
Daiichi to make hypertension combo therapy in Japan
Drug major Daiichi Sankyo has received approval in Japan to manufacture and market Rezaltas combination tablets LD and HD for the treatment of hypertension.
Novartis gets Japanese approval for three medicines
Novartis has received Japanese drug regulator's nod to launch three medicines for Diabetes, high BP and kidney cancer
PRODUCTS
Abbott's XIENCE V gets MHLW approval
Abbott announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. The company plans to launch XIENCE V in Japan soon
Nu Skin launches ageLOC product in Japan
Nu Skin Enterprises introduced the new ageLOC Future Serum to more than 10,000 sales representatives at its launch event in Japan. Japanese distributors were eager to be in the first market to fully launch one of the company's new ageLOC skin care
TRENDS & ANALYSIS
Japanese peripheral vascular stent procedures to expand at 11 % CAGR till 2014
According to Millennium Research Group, Japan's complex regulatory environment and lengthy device approval process has created a significant lag in peripheral vascular stenting device availability in the country compared to other developed nations
Patent protection of depression drugs will drive growth in Europe, Japan
The new Pharmacor report entitled Major Depressive Disorder finds that sales of therapies for major depression in most of Europe and Japan will increase by $500 million from 2008 to 2018
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black